Hypertrophic cardiomyopathy in childhood.

[1]  B. Maron,et al.  Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy. , 2005, Journal of the American College of Cardiology.

[2]  J. Seidman,et al.  Glycogen storage diseases presenting as hypertrophic cardiomyopathy. , 2005, The New England journal of medicine.

[3]  Barry J Maron,et al.  Proposal for contemporary screening strategies in families with hypertrophic cardiomyopathy. , 2004, Journal of the American College of Cardiology.

[4]  C. Semsarian,et al.  Long-term follow-up of implantable cardioverter defibrillator therapy for hypertrophic cardiomyopathy. , 2004, The American journal of cardiology.

[5]  B. Gersh,et al.  839-1 The long-term effect of surgical myectomy on survival in patients with obstructive hypertrophic cardiomyopathy , 2004 .

[6]  B. Maron,et al.  Role of Percutaneous Septal Ablation in Hypertrophic Obstructive Cardiomyopathy , 2004, Circulation.

[7]  J. Eriksson,et al.  Extreme hypertrophic cardiomyopathy , 2003, Heart.

[8]  Barry J Maron,et al.  American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice G , 2003, Journal of the American College of Cardiology.

[9]  I. Olivotto,et al.  Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. , 2003, The New England journal of medicine.

[10]  A. Tajik,et al.  Myocardial bridging in adult patients with hypertrophic cardiomyopathy. , 2003, Journal of the American College of Cardiology.

[11]  P. Elliott,et al.  Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients. , 2003, Journal of the American College of Cardiology.

[12]  M. Link,et al.  Primary prevention of sudden death as a novel treatment strategy in hypertrophic cardiomyopathy. , 2003, Circulation.

[13]  R. Hauer,et al.  Sudden Death in Noncoronary Heart Disease Is Associated With Delayed Paced Ventricular Activation , 2003, Circulation.

[14]  B. Maron,et al.  Relation of left ventricular thickness to age and gender in hypertrophic cardiomyopathy. , 2003, The American journal of cardiology.

[15]  M. Komajda,et al.  Hypertrophic Cardiomyopathy: Distribution of Disease Genes, Spectrum of Mutations, and Implications for a Molecular Diagnosis Strategy , 2003, Circulation.

[16]  John B Carlin,et al.  The epidemiology of childhood cardiomyopathy in Australia. , 2003, The New England journal of medicine.

[17]  E John Orav,et al.  The incidence of pediatric cardiomyopathy in two regions of the United States. , 2003, The New England journal of medicine.

[18]  F. T. ten Cate,et al.  Hypertrophic cardiomyopathy in a large community-based population: clinical outcome and identification of risk factors for sudden cardiac death and clinical deterioration. , 2003, Journal of the American College of Cardiology.

[19]  B. Maron,et al.  Relation of extreme left ventricular hypertrophy to age in hypertrophic cardiomyopathy. , 2003, The American journal of cardiology.

[20]  E. Holme,et al.  Cardiomyopathy in children with mitochondrial disease; clinical course and cardiological findings. , 2003, European heart journal.

[21]  B. Maron,et al.  Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. , 2003, The New England journal of medicine.

[22]  R. Kerber,et al.  ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). , 2002, Circulation.

[23]  S. Solomon,et al.  Assessment of Diastolic Function With Doppler Tissue Imaging to Predict Genotype in Preclinical Hypertrophic Cardiomyopathy , 2002, Circulation.

[24]  A. Tajik,et al.  Prevalence and age-dependence of malignant mutations in the beta-myosin heavy chain and troponin T genes in hypertrophic cardiomyopathy: a comprehensive outpatient perspective. , 2002, Journal of the American College of Cardiology.

[25]  B. Maron.  Hypertrophic cardiomyopathy: a systematic review. , 2002, JAMA.

[26]  B. Maron,et al.  Electrocardiogram in hypertrophic cardiomyopathy revisited: does ECG pattern predict phenotypic expression and left ventricular hypertrophy or sudden death? , 2002 .

[27]  A. Matsumori,et al.  Epidemiology of idiopathic cardiomyopathy in Japan: results from a nationwide survey , 2002, Heart.

[28]  J. Seidman,et al.  Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy. , 2002, The Journal of clinical investigation.

[29]  B. Maron,et al.  Impact of Atrial Fibrillation on the Clinical Course of Hypertrophic Cardiomyopathy , 2001, Circulation.

[30]  B. Maron,et al.  The Electrocardiogram as a Diagnostic Tool for Hypertrophic Cardiomyopathy: Revisited , 2001, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

[31]  P. Elliott,et al.  Hypertrophic Cardiomyopathy: Histopathological Features of Sudden Death in Cardiac Troponin T Disease , 2001, Circulation.

[32]  W J McKenna,et al.  Relation between myocyte disarray and outcome in hypertrophic cardiomyopathy. , 2001, The American journal of cardiology.

[33]  H Niimura,et al.  Development of left ventricular hypertrophy in adults in hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutations. , 2001, Journal of the American College of Cardiology.

[34]  Barry J. Maron,et al.  Apical hypertrophic cardiomyopathy developing at a relatively advanced age. , 2001, Circulation.

[35]  J. Seidman,et al.  The Genetic Basis for Cardiomyopathy from Mutation Identification to Mechanistic Paradigms , 2001, Cell.

[36]  P. Elliott,et al.  Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy , 2001, The Lancet.

[37]  P. Elliott,et al.  Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. , 2000, Journal of the American College of Cardiology.

[38]  L. Fananapazir,et al.  Myocardial bridging does not predict sudden death in children with hypertrophic cardiomyopathy but is associated with more severe cardiac disease. , 2000, Journal of the American College of Cardiology.

[39]  B. Maron,et al.  Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population. , 2000, Circulation.

[40]  G Thiene,et al.  Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia. , 2000, Human pathology.

[41]  B. Maron,et al.  Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. , 2000, The New England journal of medicine.

[42]  M. Link,et al.  Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. , 2000, The New England journal of medicine.

[43]  H. Watkins.  Sudden death in hypertrophic cardiomyopathy. , 2000, The New England journal of medicine.

[44]  T. Riesenfeld,et al.  A cohort study of childhood hypertrophic cardiomyopathy: improved survival following high-dose beta-adrenoceptor antagonist treatment. , 1999, Journal of the American College of Cardiology.

[45]  M. Josephson,et al.  Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double-blind, crossover study (M-PATHY). , 1999, Circulation.

[46]  B. Maron,et al.  Clinical profile of hypertrophic cardiomyopathy identified de novo in rural communities. , 1999, Journal of the American College of Cardiology.

[47]  P. Elliott,et al.  Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy. , 1999, Journal of the American College of Cardiology.

[48]  C. Autore,et al.  Infective endocarditis in hypertrophic cardiomyopathy: prevalence, incidence, and indications for antibiotic prophylaxis. , 1999, Circulation.

[49]  B. Maron,et al.  Clinical course of hypertrophic cardiomyopathy in a regional United States cohort. , 1999, JAMA.

[50]  B. Maron,et al.  Pitfalls in clinical recognition and a novel operative approach for hypertrophic cardiomyopathy with severe outflow obstruction due to anomalous papillary muscle. , 1998, Circulation.

[51]  B. McCrindle,et al.  Myocardial bridging in children with hypertrophic cardiomyopathy--a risk factor for sudden death. , 1998, The New England journal of medicine.

[52]  A. Moss,et al.  Impact of laboratory molecular diagnosis on contemporary diagnostic criteria for genetically transmitted cardiovascular diseases: hypertrophic cardiomyopathy, long-QT syndrome, and marfan syndrome : A statement for healthcare professionals from the councils on clinical cardiology, cardiovascular dis , 1998, Circulation.

[53]  T. Imaizumi,et al.  Predictors of sudden cardiac death in hypertrophic cardiomyopathy. , 1998, The American journal of cardiology.

[54]  Asso,et al.  Screening for hypertrophic cardiomyopathy in young athletes. , 1998, The New England journal of medicine.

[55]  M. Komajda,et al.  Clinical features and prognostic implications of familial hypertrophic cardiomyopathy related to the cardiac myosin-binding protein C gene. , 1998, Circulation.

[56]  B. Maron,et al.  Implications of left ventricular remodeling in hypertrophic cardiomyopathy. , 1998, The American journal of cardiology.

[57]  H Niimura,et al.  Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. , 1998, The New England journal of medicine.

[58]  B. Maron,et al.  Prognostic value of non-sustained ventricular tachycardia and the potential role of amiodarone treatment in hypertrophic cardiomyopathy: assessment in an unselected non-referral based patient population , 1998, Heart.

[59]  M. Komajda,et al.  Familial hypertrophic cardiomyopathy. Cardiac ultrasonic abnormalities in genetically affected subjects without echocardiographic evidence of left ventricular hypertrophy. , 1998, European heart journal.

[60]  P. Grayburn,et al.  Spontaneous Variability of Left Ventricular Outflow Tract Gradient in Hypertrophic Obstructive Cardiomyopathy , 1998, Circulation.

[61]  S. Pipitone,et al.  Clinical profile and prognosis of hypertrophic cardiomyopathy when first diagnosed in infancy as opposed to childhood , 1997, Cardiology in the Young.

[62]  O. Simell,et al.  Epidemiology of idiopathic cardiomyopathies in children and adolescents. A nationwide study in Finland. , 1997, American journal of epidemiology.

[63]  W. Mckenna,et al.  The management of hypertrophic cardiomyopathy. , 1997, The New England journal of medicine.

[64]  H. Watkins,et al.  Sudden death due to troponin T mutations. , 1997, Journal of the American College of Cardiology.

[65]  J. Skinner,et al.  A regional study of presentation and outcome of hypertrophic cardiomyopathy in infants. , 1997, Heart.

[66]  W. Mckenna,et al.  Experience from clinical genetics in hypertrophic cardiomyopathy: proposal for new diagnostic criteria in adult members of affected families. , 1997, Heart.

[67]  G. Danielson,et al.  Hypertrophic obstructive cardiomyopathy in pediatric patients: results of surgical treatment. , 1996, The Journal of thoracic and cardiovascular surgery.

[68]  M. Moss.  A U.S. experiment on young children ignites painful debate. , 1996, Wall Street journal.

[69]  B. Maron,et al.  Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. , 1995, Journal of the American College of Cardiology.

[70]  B. Maron,et al.  Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population. , 1995, Journal of the American College of Cardiology.

[71]  F. Van de Werf,et al.  Impaired myocardial tissue perfusion early after successful thrombolysis. Impact on myocardial flow, metabolism, and function at late follow-up. , 1995, Circulation.

[72]  W. Williams,et al.  Hypertrophic cardiomyopathy. Clinical spectrum and treatment. , 1995, Circulation.

[73]  J. Gardin,et al.  Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. , 1995, Circulation.

[74]  J. Seidman,et al.  Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy. , 1995, The New England journal of medicine.

[75]  B. Maron,et al.  Cardiac disease in young trained athletes. Insights into methods for distinguishing athlete's heart from structural heart disease, with particular emphasis on hypertrophic cardiomyopathy. , 1995, Circulation.

[76]  M. Komajda,et al.  Molecular basis of familial cardiomyopathies. , 1995, Circulation.

[77]  C. Autore,et al.  Prognosis of Asymptomatic Patients With Hypertrophic Cardiomyopathy and Nonsustained Ventricular Tachycardia , 1994, Circulation.

[78]  B. Maron,et al.  Task force 3: Hypertrophic cardiomyopathy, myocarditis and other myopericardial diseases and mitral valve prolapse , 1994 .

[79]  B. Maron,et al.  Prevalence of hypertrophic cardiomyopathy in an outpatient population referred for echocardiographic study. , 1994, The American journal of cardiology.

[80]  B. Maron,et al.  Impact of patient selection biases on the perception of hypertrophic cardiomyopathy and its natural history. , 1993, The American journal of cardiology.

[81]  M. Sherrid,et al.  An echocardiographic study of the fluid mechanics of obstruction in hypertrophic cardiomyopathy. , 1993, Journal of the American College of Cardiology.

[82]  W. Roberts,et al.  Clinicopathologic features of hypertrophic cardiomyopathy managed by cardiac transplantation. , 1993, The American journal of cardiology.

[83]  W. Roberts,et al.  Coexistence of sudden cardiac death and end-stage heart failure in familial hypertrophic cardiomyopathy. , 1993, Journal of the American College of Cardiology.

[84]  M. Silka,et al.  Sudden Cardiac Death and the Use ofImplantable Cardioverter‐Defibrillators in Pediatric Patients , 1993, Circulation.

[85]  W. Roberts,et al.  Diversity of Structural Mitral Valve Alterations in Hypertrophic Cardiomyopathy , 1992, Circulation.

[86]  B. Maron,et al.  Development and Determinants of Dynamic Obstruction to Left Ventricular Outflow in Young Patients With Hypertrophic Cardiomyopathy , 1992, Circulation.

[87]  P. Nihoyannopoulos,et al.  Diastolic function in hypertrophic cardiomyopathy: relation to exercise capacity. , 1992, Journal of the American College of Cardiology.

[88]  W. Roberts,et al.  Anomalous Insertion of Papillary Muscle Directly Into Anterior Mitral Leaflet in Hypertrophic Cardiomyopathy: Significance in Producing Left Ventricular Outflow Obstruction , 1991, Circulation.

[89]  B. Maron,et al.  Relation of electrocardiographic abnormalities to evolving left ventricular hypertrophy in hypertrophic cardiomyopathy during childhood. , 1989, The American journal of cardiology.

[90]  B. Maron,et al.  Long-term outcome of patients with hypertrophic cardiomyopathy successfully resuscitated after cardiac arrest. , 1989, Journal of the American College of Cardiology.

[91]  M. Z. Berisso,et al.  Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatient population. , 1989, The New England journal of medicine.

[92]  M. Sherrid,et al.  Oral disopyramide therapy for obstructive hypertrophic cardiomyopathy. , 1988, The American journal of cardiology.

[93]  R. Kloner,et al.  Evaluation of nonradioactive, colored microspheres for measurement of regional myocardial blood flow in dogs. , 1988, Circulation.

[94]  K. Peterson,et al.  Hypertrophic cardiomyopathy and sudden death. , 1988, The New England journal of medicine.

[95]  W. Williams,et al.  Results of surgery for hypertrophic obstructive cardiomyopathy. , 1987, Circulation.

[96]  R. Bonow,et al.  Noninvasive assessment of left ventricular diastolic function by pulsed Doppler echocardiography in patients with hypertrophic cardiomyopathy. , 1987, Journal of the American College of Cardiology.

[97]  B. Maron,et al.  Apical Hypertrophic Cardiomyopathy: Clinical and Two-Dimensional Echocardiographic Assessment , 1987, Annals of internal medicine.

[98]  D. Human,et al.  Hypertrophic cardiomyopathy in infancy and childhood. , 1987, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[99]  R. Bonow,et al.  Hypertrophic cardiomyopathy. , 1987, Disease-a-month : DM.

[100]  G. Hausdorf,et al.  Primary (genetic) cardiomyopathies in infancy. A survey of possible disorders and guidelines for diagnosis , 1986, European Journal of Pediatrics.

[101]  B. Maron,et al.  Development and progression of left ventricular hypertrophy in children with hypertrophic cardiomyopathy. , 1986, The New England journal of medicine.

[102]  W. Roberts,et al.  Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy. , 1986, Journal of the American College of Cardiology.

[103]  W. Williams,et al.  Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review. , 1985, Progress in cardiovascular diseases.

[104]  R. Bonow,et al.  Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures. , 1985, Circulation.

[105]  J. Deanfield,et al.  Hypertrophic cardiomyopathy: an important cause of sudden death. , 1984, Archives of disease in childhood.

[106]  A. Rocchini,et al.  Chronic verapamil therapy in pediatric and young adult patients with hypertrophic cardiomyopathy. , 1984, The American journal of cardiology.

[107]  W. Roberts,et al.  Systolic anterior motion of the posterior mitral leaflet: a previously unrecognized cause of dynamic subaortic obstruction in patients with hypertrophic cardiomyopathy. , 1983, Circulation.

[108]  H. Klein,et al.  Temporal and spatial development of infarcts in porcine hearts , 1983, Basic Research in Cardiology.

[109]  R. Rowe,et al.  Hypertrophic cardiomyopathy presenting before 2 years of age in 13 patients , 1983, Pediatric Cardiology.

[110]  W. Roberts,et al.  Hypertrophic Cardiomyopathy in Infants: Clinical Features and Natural History , 1982, Circulation.

[111]  Michael V. Green,et al.  Effects of Verapamil on Left Ventricular Systolic Function and Diastolic Filling in Patients with Hypertrophic Cardiomyopathy , 1981, Circulation.

[112]  J. Gottdiener,et al.  Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy. A wide angle, two dimensional echocardiographic study of 125 patients. , 1981, The American journal of cardiology.

[113]  M. Wong,et al.  Abnormal mitral valve coaptation in hypertrophic obstructive cardiomyopathy: proposed role in systolic anterior motion of mitral valve. , 1981, The American journal of cardiology.

[114]  W. Roberts,et al.  Sudden Death in Young Athletes , 1980, Circulation.

[115]  W. Roberts,et al.  Quantitative Analysis of Cardiac Muscle Cell Disorganization in the Ventricular Septum of Patients with Hypertrophic Cardiomyopathy , 1979, Circulation.

[116]  B. Maron,et al.  Disproportionate Ventricular Septal Thickening in the Developing Normal Human Heart , 1978, Circulation.

[117]  W. Roberts,et al.  Asymmetric Septal Hypertrophy in Childhood , 1976, Circulation.

[118]  W. Henry,et al.  Operative Treatment in Hypertrophic Subaortic Stenosis: Techniques, and the Results of Pre and Postoperative Assessments in 83 Patients , 1975, Circulation.

[119]  V. Ferrans,et al.  Myocardial Ultrastructure in Idiopathic Hypertrophic Subaortic Stenosis: A Study of Operatively Excised Left Ventricular Outflow Tract Muscle in 14 Patients , 1972, Circulation.

[120]  E. Braunwald,et al.  Idiopathic Hypertrophic Subaortic Stenosis: Clinical Analysis of 126 Patients with Emphasis on the Natural History , 1968, Circulation.

[121]  C. Lambrew,et al.  Idiopathic Hypertrophic Subaortic Stenosis: I. A Description of the Disease Based Upon an Analysis of 64 Patients , 1964, Circulation.

[122]  D TEARE,et al.  ASYMMETRICAL HYPERTROPHY OF THE HEART IN YOUNG ADULTS , 1958, British heart journal.

[123]  R. Hui,et al.  Prevalence of idiopathic hypertrophic cardiomyopathy in China: a population-based echocardiographic analysis of 8080 adults. , 2004, The American journal of medicine.

[124]  B. Maron.  Hypertrophic cardiomyopathy: an important global disease. , 2004, The American journal of medicine.

[125]  E. D. Wigle,et al.  Expert consensus document American College of Cardiology / European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy , 2003 .

[126]  A. Tajik,et al.  Prevalence and Severity of “Benign” Mutations in the β-Myosin Heavy Chain, Cardiac Troponin T, and α-Tropomyosin Genes in Hypertrophic Cardiomyopathy , 2002, Circulation.

[127]  W. Roberts,et al.  Morphology and significance of the left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden cardiac death. , 2000, Journal of the American College of Cardiology.

[128]  S. Solomon,et al.  Prognostic implications of novel beta cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy. , 1994, The Journal of clinical investigation.

[129]  J. Webb,et al.  Apical hypertrophic cardiomyopathy: clinical follow-up and diagnostic correlates. , 1990, Journal of the American College of Cardiology.

[130]  R. Franklin,et al.  Arrhythmia and prognosis in infants, children and adolescents with hypertrophic cardiomyopathy. , 1988, Journal of the American College of Cardiology.

[131]  R. Cannon.  Myocardial ischemia in hypertrophic cardiomyopathy. , 1987, Zeitschrift fur Kardiologie.